Clinical Trials Directory

Trials / Completed

CompletedNCT01529502

Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting

Effects of Stored Red Blood Cell Transfusion in Overweight Subjects With Endothelial Dysfunction: Influence of Inhaled Nitric Oxide (iNO)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether storage time affects how human body responds to autologous blood transfusion. An autologous blood transfusion is when a person donates blood and then receives that same blood back in the transfusion. We also want to find out if in this situation inhaled nitric oxide can help to prevent the potential reduction of vasodilation capacity. Vasodilation capacity is the ability of the blood vessel to widen when needed.

Detailed description

The objective of this study is to assess effects of the storage of PRBC on pulmonary vasoconstriction measured as increase in pulmonary artery pressure and endothelial function measured as a change in reactive hyperemia index in overweight people with existing endothelial dysfunction at baseline. The present study consists of three different parts, which will be scheduled in a randomized order on the same subject (crossover study). During one phase of the study, 14 healthy human volunteers will donate a unit of Packed Red Blood Cells (PRBC), which will be leukoreduced and stored in Additive Solutions-1 (AS-1), and then transfused back to the subjects after 3 days of storage at 4º C in the MGH Blood Bank (Fresh Blood arm). The second part of the study consists in the collection of another unit of PRBC from the same volunteers which will be transfused back to them after 40 days of storage (Old Blood arm). Finally in the third part, like in the second one, one unit of PRBC will be withdraw and stored for 40 days, but 80 ppm (parts per million by volume) Nitric Oxide in air will be administered together with the transfusion. There will be a 2 weeks interval after each PRBC transfusion. We hypothesize that old red blood cells stored under conventional conditions may trigger a complex, pro-inflammatory, pro-thrombotic and vasoconstriction response. We will compare the response to PRBC stored for 3 days with the response to PRBC stored for 40 days in the same healthy volunteers. We also want to test the hypothesis that inhaled nitric oxide may reverse these adverse effects. We will monitor/measure the following parameters: 1. Pulmonary vasoconstriction by trans-thoracic echocardiography 2. Endothelium-mediated changes in vascular (arterial) tone, measured as reactive hyperemia index.

Conditions

Interventions

TypeNameDescription
PROCEDURERed blood Cells auto-transfusionWithdrawal from 14 overweight volunteers of one unit of red blood cells and auto-transfusion after 3 days storage time. The same 14 subjects will be included in every arm of the study.
PROCEDURERed blood Cells auto-transfusionWithdrawal from the same 14 overweight volunteers of one unit of red blood cells and auto-transfusion after 40 days storage time.
DRUGInhaled Nitric Oxide (iNO) administrationSubjects will breath iNO (80ppm) for 10 minutes before, during and for one hour after the autologous old-blood transfusion.

Timeline

Start date
2012-03-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-02-08
Last updated
2017-05-22
Results posted
2017-03-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01529502. Inclusion in this directory is not an endorsement.

Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting (NCT01529502) · Clinical Trials Directory